This report shows monthly numbers of NHS Hospital and Community Health Services (HCHS) staff working in NHS Trusts and other core organisations in England (excluding primary care staff). Data are available as headcount and full-time equivalents and for all months from 30 September 2009 onwards. These data are a summary of the validated data extracted from the NHS HR and Payroll system. Additional statistics on staff in NHS Trusts and other core organisations and information for NHS Support Organisations and Central Bodies are published each: September (showing June statistics) December/January (showing September statistics) March (showing December statistics) June (showing March statistics) Quarterly NHS Staff Earnings, monthly NHS Staff Sickness Absence reports, and data relating to the General Practice workforce and the Independent Healthcare Provider workforce are also available via the Related Links below. We welcome feedback on the methodology and tables within this publication. Please email us with your comments and suggestions, clearly stating Monthly HCHS Workforce as the subject heading, via enquiries@nhsdigital.nhs.uk or 0300 303 5678.

Initially this data is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). This is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver. This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Because these uses are not to do with direct patient care, they are called 'secondary uses'. This is the SUS data set. SUS data covers all NHS Clinical Commissioning Groups (CCGs) in England, including: • private patients treated in NHS hospitals • patients resident outside of England • care delivered by treatment centres (including those in the independent sector) funded by the NHS Each SUS record contains a wide range of information about an individual patient admitted to an NHS hospital, including: • clinical information about diagnoses and operations • patient information, such as age group, gender and ethnicity • administrative information, such as dates and methods of admission and discharge • geographical information such as where patients are treated and the area where they live NHS Digital apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published SUS data. This suppresses small numbers to stop people identifying themselves and others, to ensure that patient confidentiality is maintained.

Who SUS is for SUS provides data for the purpose of healthcare analysis to the NHS, government and others including:

The Secondary Users Service (SUS) database is made up of many data items relating to A&E care delivered by NHS hospitals in England. Many of these items form part of the national Commissioning Data Set (CDS), and are generated by the patient administration systems within each hospital. • national bodies and regulators, such as the Department of Health, NHS England, Public Health England, NHS Improvement and the CQC • local Clinical Commissioning Groups (CCGs) • provider organisations • government departments • researchers and commercial healthcare bodies • National Institute for Clinical Excellence (NICE) • patients, service users and carers • the media

Uses of the statistics The statistics are known to be used for: • national policy making • benchmarking performance against other hospital providers or CCGs
• academic research • analysing service usage and planning change • providing advice to ministers and answering a wide range of parliamentary questions • national and local press articles • international comparison More information can be found at https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics https://digital.nhs.uk/data-and-information/publications/statistical/hospital-accident--emergency-activity"

Notes:

Initially this data is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). This is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver. This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Because these uses are not to do with direct patient care, they are called 'secondary uses'. This is the SUS data set. SUS data covers all NHS Clinical Commissioning Groups (CCGs) in England, including: 1. private patients treated in NHS hospitals 2. patients resident outside of England 3. care delivered by treatment centres (including those in the independent sector) funded by the NHS

Each SUS record contains a wide range of information about an individual patient admitted to an NHS hospital, including: 1. clinical information about diagnoses and operations 2. patient information, such as age group, gender and ethnicity 3. administrative information, such as dates and methods of admission and discharge 4. geographical information such as where patients are treated and the area where they live

NHS Digital apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published SUS data. This suppresses small numbers to stop people identifying themselves and others, to ensure that patient confidentiality is maintained.

Who SUS is for SUS provides data for the purpose of healthcare analysis to the NHS, government and others including:

The Secondary Users Service (SUS) database is made up of many data items relating to A&E care delivered by NHS hospitals in England. Many of these items form part of the national Commissioning Data Set (CDS), and are generated by the patient administration systems within each hospital. 1. national bodies and regulators, such as the Department of Health, NHS England, Public Health England, NHS Improvement and the CQC 2. local Clinical Commissioning Groups (CCGs) 3. provider organisations 4. government departments 5. researchers and commercial healthcare bodies 6. National Institute for Clinical Excellence (NICE) 7. patients, service users and carers 8. the media

Uses of the statistics The statistics are known to be used for: 1. national policy making 2. benchmarking performance against other hospital providers or CCGs
3. academic research 4. analysing service usage and planning change 5. providing advice to ministers and answering a wide range of parliamentary questions 6. national and local press articles 7. international comparison

More information can be found at https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics https://digital.nhs.uk/data-and-information/publications/statistical/hospital-accident--emergency-activity"

In 2023, there were nearly 11 thousand hospitals in Columbia, the highest number among OECD countries, followed by 8,156 hospitals in Japan. If only general hospitals were counted (excluding mental health hospitals and other specialized hospitals), Japan had the most number of general hospitals among OECD countries worldwide. Most countries reported hospitals numbers similar to or lower than the previous year. Meanwhile, Mexico, South Korea and the Netherlands all reported more hospitals than last year.

Notes:

Percentage of emergency admissions to any hospital in England occurring within 30 days of the last, previous discharge from hospital after admission: indirectly standardised by age, sex, method of admission and diagnosis/procedure. The indicator is broken down into the following demographic groups for reporting: ● All years and female only, male only and both male and female (persons). ● <16 years and female only, male only and both male and female (persons). ● 16+ years and female only, male only and both male and female (persons) ● 16-74 years and female only, male only and both male and female (persons) ● 75+ years and female only, male only and both male and female (persons) Results for each of these groups are also split by the following geographical and demographic breakdowns: ● Local authority of residence. ● Region. ● Area classification. ● NHS and private providers. ● NHS England regions. ● Deprivation (Index of Multiple Deprivation (IMD) Quintiles, 2019). ● Sustainability and Transformation Partnerships (STP) & Integrated Care Boards (ICB) from 2016/17. ● Clinical Commissioning Groups (CCG) & sub-Integrated Care Boards (sub-ICB). All annual trends are indirectly standardised against 2013/14.

The NHS Business Services Authority (NHSBSA) publishes Secondary Care Medicines Data on behalf of NHS England (NHSE). This dataset provides 'Provisional' Secondary Care Medicines data for all NHS Acute, Teaching, Specialist, Mental Health, and Community Trusts in England. It provides information on pharmacy stock control, reflecting processed medicines data. RX Info is responsible for refreshing the Provisional data at the close of each financial year to include backtracking adjustments. The data is 'Finalised' to provide validated and complete figures for each reporting period, incorporating any updates and corrections throughout the year. The Finalised dataset serves as the definitive record for each month and year, offering the most accurate information on medicines issued. While we do not analyse changes, users can compare the finalised data with provisional data to identify any discrepancies. Key Components of the Data Quantities of Medicines Issued: Details the total quantities of medicines stock control via NHS Secondary Care services. Indicative Costs: Actual costs cannot be displayed in the dataset as NHS Hospital pricing contracts and NICE Patient Access Schemes are confidential. The indicative cost of medicines is derived from current medicines pricing data held in NHSBSA data systems (Common Drug Reference and dm+d), calculated to VMP level. Indicative costs are calculated using: Community pharmacy reimbursement prices for generic medicines. List prices for branded medicines. Care should be taken when interpreting and analysing this indicative cost as it does not reflect the net actual cost of NHS Trusts, which will differ due to the application of confidential discounts, rebates, or procurement agreements paid by hospitals when purchasing medicines. Standardisation with SNOMED CT and dm+d: SNOMED CT (Systematised Nomenclature of Medicine - Clinical Terms) is used to enhance the dataset’s compatibility with electronic health record systems and clinical decision support tools. SNOMED CT is a globally recognised coding system that provides precise definitions for clinical terms, ensuring interoperability across healthcare systems. Trust-Level Data: Data is broken down by individual NHS Trusts, enabling regional comparisons, benchmarking, and targeted analysis of specific Trusts. Medicine Identification: Medicines in the dataset are identified using Virtual Medicinal Product (VMP) codes from the Dictionary of Medicines and Devices (dm+d): VMP_PRODUCT_NAME: The name of the Virtual Medicinal Product (VMP) as defined by the dm+d, which includes key details about the product. For example: Paracetamol 500mg tablets. VMP_SNOMED_CODE: The code for the Virtual Medicinal Product (VMP), providing a unique identifier for each product. For example: 42109611000001109 represents Paracetamol 500mg tablets. You can access the finalised files in our Finalised Secondary Care Medicines Data (SCMD) with indicative price dataset.

This is a publication on maternity activity in English NHS hospitals. This report examines data relating to delivery and birth episodes in 2021-22, and the booking appointments for these deliveries. This annual publication covers the financial year ending March 2022. Data is included from both the Hospital Episodes Statistics (HES) data warehouse and the Maternity Services Data Set (MSDS). HES contains records of all admissions, appointments and attendances for patients admitted to NHS hospitals in England. The HES data used in this publication are called 'delivery episodes'. The MSDS collects records of each stage of the maternity service care pathway in NHS-funded maternity services, and includes information not recorded in HES. The MSDS is a maturing, national-level dataset. In April 2019 the MSDS transitioned to a new version of the dataset. This version, MSDS v2.0, is an update that introduced a new structure and content - including clinical terminology, in order to meet current clinical practice and incorporate new requirements. It is designed to meet requirements that resulted from the National Maternity Review, which led to the publication of the Better Births report in February 2016. This is the third publication of data from MSDS v2.0 and data from 2019-20 onwards is not directly comparable to data from previous years. This publication shows the number of HES delivery episodes during the period, with a number of breakdowns including by method of onset of labour, delivery method and place of delivery. It also shows the number of MSDS deliveries recorded during the period, with breakdowns including the baby's first feed type, birthweight, place of birth, and breastfeeding activity; and the mothers' ethnicity and age at booking. There is also data available in a separate file on breastfeeding at 6 to 8 weeks. The count of Total Babies includes both live and still births, and previous changes to how Total Babies and Total Deliveries were calculated means that comparisons between 2019-20 MSDS data and later years should be made with care. The MethodfDelivery measure counting babies has been replaced by the DeliveryMethodBabyGroup measure which counts deliveries, and the smoking at booking and folic acid status measures have been renamed - these changes have been made to better align this annual publication with the Maternity Services Monthly Statistics publication. Information on how all measures are constructed can be found in the HES Metadata and MSDS Metadata files provided below. In this publication we have also included an interactive Power BI dashboard to enable users to explore key NHS Maternity Statistics measures. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care. This report will also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. Any feedback on this publication or dashboard can be provided to enquiries@nhsdigital.nhs.uk, under the subject “NHS Maternity Statistics”.

In 2025, out of the 395 thousand registered doctors in the United Kingdom, 202 thousand were men and 193 thousand were women. There was a more pronounced gender gap among specialist doctors in the UK, with 69 thousand men to nearly 44 thousand women qualified on the specialist register. Although on the GP register, women outnumber men with over 45 thousand female GPs to nearly 35 thousand male GPs. Gender distribution of UK doctors by age While there are more male doctors than female doctors in total, the gender distribution of doctors in the UK looks different depending on the age group. Female doctors outnumber their male counterpart in all age groups under 45 years old. Therefore, as more doctors retire, the proportion of female doctors will increase. Worldwide make-up of doctors in the UK Although the majority of medical practitioners in the UK received their medical qualification from within the UK, there is still a significant number of doctors who graduated outside the UK. As of 2024, some 10 percent of registered doctors in the UK are from the European Economic Area (EEA) while a further third are international medical graduates (IMG) indicating the reliance of the NHS on immigration to support the organization’s workforce.

This publication looks at Accident and Emergency activity in England for the financial year 2023-24. It describes NHS accident and emergency activity and performance in hospitals in England. The data sources for this publication are the Emergency Care Data Set (ECDS) and Emergency Admissions Monthly Situation Reports (MSitAE) relating to A&E attendances in NHS hospitals, minor injury units and walk-in centres. The report includes analysis by patient demographics, time spent in A&E, distributions by time of arrival and day of week, arriving by ambulance, performance times, waits for admission and reattendances to A&E within 7 days. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care and may also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. Note: the MSitAE figures presented in the 'MSitAE Report Tables' file account for revisions to historic data and may therefore differ slightly from those shown in the 'Quality Indicators (CQI) Open Data' file, which is based on data published at fixed points in the year. The MSitAE data referenced throughout this report are published monthly by NHS England on the separate 'NHS England MSitAE Home Page', as linked to in the Related Links section below. This publication includes the total number of attendances for all A&E types, including Urgent Treatment Centres, Minor Injury Units and Walk-in Centres, and of these, the number discharged, admitted or transferred within four hours of arrival. Also included are the number of Emergency Admissions, and any waits of over four hours for admission following decision to admit. Contact details Author: Secondary Care Open Data and Publications; Activity Capacity & Planning, NHS England Responsible Statistician: Karl Eichler Email: enquiries@nhsdigital.nhs.uk Press enquiries should be made to: Media Relations Manager: telephone 0300 303 3888

Number of weekly Covid-19 related hospital admissions to University Hospitals Leicester (UHL) for Leicester residents. Data where the count is less than 3 admissions have been suppressed to "..". Data is updated weekly and previous week data is subject to change when data is refreshed.Note: This dataset will soon be archived and not subject to updates. A replacement dataset is currently under development.

In the second quarter of 2024/25, there were approximately 6.7 million attendances in the accident and emergency department nationwide. A&E attendance has been increasing in the recorded time period, except for during the COVID pandemic. This statistic displays the total accident and emergency attendances in England, from the first quarter of 2012/13 to the second quarter of 2024/25.

As of September 2024, there were 146,387 full-time equivalent (FTE) doctors in NHS Hospitals and Community Health Services (HCHS) in England, which is more than two thousand times the number reported in September 1995.

The UK Cystic Fibrosis Registry Transplants is made up of many data items relating to transplant journey(s) taken by CF patients at NHS hospitals in UK.

Notes:

This publication of the SHMI relates to discharges in the reporting period August 2023 - July 2024. The SHMI is the ratio between the actual number of patients who die following hospitalisation at the trust and the number that would be expected to die on the basis of average England figures, given the characteristics of the patients treated there. The SHMI covers patients admitted to hospitals in England who died either while in hospital or within 30 days of being discharged. To help users of the data understand the SHMI, trusts have been categorised into bandings indicating whether a trust's SHMI is 'higher than expected', 'as expected' or 'lower than expected'. For any given number of expected deaths, a range of observed deaths is considered to be 'as expected'. If the observed number of deaths falls outside of this range, the trust in question is considered to have a higher or lower SHMI than expected. The expected number of deaths is a statistical construct and is not a count of patients. The difference between the number of observed deaths and the number of expected deaths cannot be interpreted as the number of avoidable deaths or excess deaths for the trust. The SHMI is not a measure of quality of care. A higher than expected number of deaths should not immediately be interpreted as indicating poor performance and instead should be viewed as a 'smoke alarm' which requires further investigation. Similarly, an 'as expected' or 'lower than expected' SHMI should not immediately be interpreted as indicating satisfactory or good performance. Trusts may be located at multiple sites and may be responsible for 1 or more hospitals. A breakdown of the data by site of treatment is also provided, as well as a breakdown of the data by diagnosis group. Further background information and supporting documents, including information on how to interpret the SHMI, are available on the SHMI homepage (see Related Links).

IntroductionPeople living with dementia (PwD) admitted in emergency to an acute hospital may be at higher risk of inappropriate care and poorer outcomes including longer hospitalisations and higher risk of emergency re-admission or death. Since 2009 numerous national and local initiatives in England have sought to improve hospital care for PwD. We compared outcomes of emergency admissions for cohorts of patients aged 65+ with and without dementia at three points in time.MethodsWe analysed emergency admissions (EAs) from the Hospital Episodes Statistics datasets for England 2010/11, 2012/13 and 2016/17. Dementia upon admission was based on a diagnosis in the patient’s hospital records within the last five years. Outcomes were length of hospital stays (LoS), long stays (> = 15 days), emergency re-admissions (ERAs) and death in hospital or within 30 days post-discharge. A wide range of covariates were taken into account, including patient demographics, pre-existing health and reasons for admission. Hierarchical multivariable regression analysis, applied separately for males and females, estimated group differences adjusted for covariates.ResultsWe included 178 acute hospitals and 5,580,106 EAs, of which 356,992 (13.9%) were male PwD and 561,349 (18.6%) female PwD. Uncontrolled differences in outcomes between the patient groups were substantial but were considerably reduced after control for covariates. Covariate-adjusted differences in LoS were similar at all time-points and in 2016/17 were 17% (95%CI 15%-18%) and 12% (10%-14%) longer for male and female PwD respectively compared to patients without dementia. Adjusted excess risk of an ERA for PwD reduced over time to 17% (15%-18%) for males and 17% (16%-19%) for females, but principally due to increased ERA rates amongst patients without dementia. Adjusted overall mortality was 30% to 40% higher for PwD of both sexes throughout the time-period; however, adjusted in-hospital rates of mortality differed only slightly between the patient groups, whereas PwD had around double the risk of dying within 30 days of being discharged.ConclusionOver the six-year period, covariate-adjusted hospital LoS, ERA rates and in-hospital mortality rates for PwD were only slightly elevated compared to similar patients without dementia and remaining differences potentially reflect uncontrolled confounding. PwD however, were around twice as likely to die shortly after discharge, the reasons for which require further investigation. Despite being widely used for service evaluation, LoS, ERA and mortality may lack sensitivity to changes in hospital care and support to PwD.

Notes: